…
Continue Reading about The Impact and Management of Mental Health on Patients With Psoriasis →
A New Era in GPP Treatment: Clinical Insights, Biomarkers, and Emerging Therapies
Clinical Insights into Psoriasis in Patients of Color: Bringing New Data to Light
Various gaps in the management of psoriasis in patients with SOC persist due to a lack of training for dermatology practitioners. As a result, patients with SOC are often misdiagnosed, experience more …
Psoriasis in Skin of Color Unplugged: Addressing the Barriers to Patient Care and Relief
Various gaps in the management of psoriasis patients with SOC persist due to a lack of training on SOC and inherent barriers to care. As a result, psoriasis patients with SOC are often misdiagnosed, …
Impact of Psoriasis and Psoriatic Arthritis: What Matters When Engaging with Patients
Psoriasis (PsO) is a disease in which rough, scaly patches of skin develop on a significant portion of the body, most commonly the knees, elbows, trunk, and scalp. This condition has daily negative …
Updates on Interleukin-17 Inhibition for Moderate to Severe Psoriasis
This activity is intended for dermatologists, rheumatologists, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients with psoriasis. The goal of this activity …
Continue Reading about Updates on Interleukin-17 Inhibition for Moderate to Severe Psoriasis →